EGFR and lung carcinoma: Therefore, detection of lung-cancer-specific mutant EGFR DNA in BALF along with compatible CT findings suggesting malignancy may be sufficient to diagnose EGFR-mutant lung cancer to guide EGFR-TKI treatment.